lipids - CISMeF

Preferred Label : lipids;

MeSH definition : A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed);

MeSH synonym : Lipid;

MeSH annotation : GEN or unspecified only: prefer specifics; differentiate from FATS (outside the body); /blood: consider also HYPERLIPIDEMIAS & specifics; dyslipidemia, especially in foreign lit, is probably HYPERLIPIDEMIAS or its specifics; DIETARY FATS is also available; general or unspecified; prefer specifics; differentiate from FATS; / blood: consider also HYPERLIPIDEMIAS & specifics; dyslipidemia, especially in foreign literature, is probably HYPERLIPIDEMIAS or its specifics; DIETARY FATS is also available; general or unspecified; prefer specifics; differentiate from FATS; /blood: consider also HYPERLIPIDEMIAS & specifics; dyslipidemia, especially in foreign literature, is probably HYPERLIPIDEMIAS or its specifics; DIETARY FATS is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Lipid;

Is substance : O;

Details

Origin ID

D008055;

UMLS CUI

C0023779;

ATC code(s)
- fat/carbohydrates/proteins/minerals/vitamins, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lipid Measurement [NCIt concept]
- Lipids [PASCAL descriptor]
- Lipids [EDAM topic]
- Lipids [HPMULTI term]
- Lipids [PASCAL theme]
- Lipids [PASCAL theme]
- Lipids NOS low [MedDRA LLT]
- Lipids increased [MedDRA Preferred Term]
- dietary fats [MedlinePlus Topic]
- lipid [Blood Transfusion thesaurus concept]
- lipid [Artificial nutrition thesaurus concept]
Currated CISMeF NLP mapping
- Lipid [FMA entity]
- Lipid [NCIt concept]
- Lipid (substance) [SNOMED CT concept]
- Lipids [MedDRA Preferred Term]
- Lipids [LOINC component]
- Lipids NOS [MedDRA LLT]
- lipid [Radlex concept]
- lipid, nos [SNOMED Notion]
- lipids [IUPAC Term]
Indexing information
- 2,3-dioleyloxy-N-(2-(sperminecarboxamido)ethyl)-N,N-dimethyl-1-propanaminium trifluoroacetate [MeSH Supplementary Concept]
- ATLP-1 protein, arabidopsis [MeSH Supplementary Concept]
- N-stearoylethanolamine [MeSH Supplementary Concept]
- P-LF II D [MeSH Supplementary Concept]
- capnine [MeSH Supplementary Concept]
- curacin A [MeSH Supplementary Concept]
- moenocinol [MeSH Supplementary Concept]
- oleosin 24 protein, glycine max [MeSH Supplementary Concept]
- oleosin Bn-III protein, brassica napus [MeSH Supplementary Concept]
- oleosin protein, brassica napus [MeSH Supplementary Concept]
- oleosin protein, daucus carota [MeSH Supplementary Concept]
- oleosin protein, gossypium hirsutum [MeSH Supplementary Concept]
- oleosin protein, radish [MeSH Supplementary Concept]
- oleosin protein, sesamum indicum [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- dietary fats [MeSH Descriptor]
Metaterm(s)
- chemistry [CISMeF Metaterm]
Record concept(s)
- lipids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2,2-bis(docosyloxymethyl)propyl-5-acetamido-3,5-dideoxy-4,7,8,9-tetra-O-(sodium oxysulfonyl)glycero-alpha-galacto-2-nonulopyranosid)onate [MeSH Supplementary Concept]
- (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium [MeSH Supplementary Concept]
- 1',2'-dioleoyl-sn-glycero-3'-succinyl-1,6-hexanediol ornithiine conjugate [MeSH Supplementary Concept]
- 1,2-bis(hexadecyloxy)-3-trimethylaminopropane [MeSH Supplementary Concept]
- 1,2-cycloundecadiene [MeSH Supplementary Concept]
- 1,2-di-n-hexadecyloxypropyl-4-(beta-nitrostyryl)phosphate [MeSH Supplementary Concept]
- 1,2-dioleoyl-sn-glycero-3-succinyl-2-hydroxyethyl disulfide ornithine conjugate [MeSH Supplementary Concept]
- 1,6,9,12,15-octadecapenten-3-one [MeSH Supplementary Concept]
- 1,9-decadiene [MeSH Supplementary Concept]
- 1-(2-(9-octadecenoyloxy)ethyl)-2-(8-heptadecenyl)-3-(hydroxyethyl)imidazolinium [MeSH Supplementary Concept]
- 1-tuberculosinyladenosine [MeSH Supplementary Concept]
- 2,3,5,6,7,15-hexachloropentadec-14-en-4-ol [MeSH Supplementary Concept]
- 2,3,5,6,7-pentachloropentadec-14-en-4-ol [MeSH Supplementary Concept]
- 2,3,5,6,7-pentachloropentadec-14-en-4-yl hydrogen sulfate [MeSH Supplementary Concept]
- 2,3-di-O-phytanyl-sn-glycerol-1-tetraethylene glycol-(3-chloro-dimethylpropyl-silane) ether lipid [MeSH Supplementary Concept]
- 2,3-di-O-phytanyl-sn-glycerol-1-tetraethylene glycol-(3-trichloropropyl-silane) ether lipid [MeSH Supplementary Concept]
- 2-(bis-carboxymethylamino)-6-(2-(1,3-di-O-oleylglyceroxy)acetylamino)hexanoic acid nickel(II) [MeSH Supplementary Concept]
- 2-amino-3-hexadecyloxy-2-(hexadecyloxymethyl)propan-1-ol [MeSH Supplementary Concept]
- 2-hydroxymethyl-1,4-dioxacycloicosane-5,20-dione [MeSH Supplementary Concept]
- 3-(N-10-undecenoyl-L-valyl)aminopropyl trimethylammonium bromide [MeSH Supplementary Concept]
- 3-(N-dodecanoyl-L-valylamino)-propyltrimethylammonium bromide [MeSH Supplementary Concept]
- 3-(hexadecanoyloxy)hexadecanoyl-ornithine [MeSH Supplementary Concept]
- 3-hydroxy-1,5-dioxacyclohenicosane-6,21-dione [MeSH Supplementary Concept]
- 5-hydroxy-5-methyl-3-(n-hexadecyl)-2(5H)-furanone [MeSH Supplementary Concept]
- 6-(N-nonanoyl-L-valylamino)-propyltrimethylammonium bromide [MeSH Supplementary Concept]
- Allovectin-7 [MeSH Supplementary Concept]
- BP 1100X [MeSH Supplementary Concept]
- Biafine [MeSH Supplementary Concept]
- DSPE-PEG-SA [MeSH Supplementary Concept]
- Endocine [MeSH Supplementary Concept]
- FuGene [MeSH Supplementary Concept]
- MBT-0206 [MeSH Supplementary Concept]
- TKM-080301 [MeSH Supplementary Concept]
- YSK05 [MeSH Supplementary Concept]
- Z-20-(Z-octadec-9-enyloxy)-6,9,12,15,18,22-heptaoxatetracont-31-ene-1-thiol [MeSH Supplementary Concept]
- actisonitrile [MeSH Supplementary Concept]
- adeps solidus [MeSH Supplementary Concept]
- amphyl [MeSH Supplementary Concept]
- angiolysin [MeSH Supplementary Concept]
- bahiensol [MeSH Supplementary Concept]
- biphasix-vaccine targeting adjuvant [MeSH Supplementary Concept]
- bromodanicalipin A [MeSH Supplementary Concept]
- caprazamycin B [MeSH Supplementary Concept]
- corexit 9500 [MeSH Supplementary Concept]
- corexit 9527 [MeSH Supplementary Concept]
- danicalipin A [MeSH Supplementary Concept]
- dioxalim [MeSH Supplementary Concept]
- diproxamine [MeSH Supplementary Concept]
- effectene [MeSH Supplementary Concept]
- eucerin [MeSH Supplementary Concept]
- fozivudine tidoxil [MeSH Supplementary Concept]
- hexachlorosulfolipid [MeSH Supplementary Concept]
- incomplete freund's adjuvant [MeSH Supplementary Concept]
- isolevuglandin [MeSH Supplementary Concept]
- kalkitoxin [MeSH Supplementary Concept]
- leucanone A [MeSH Supplementary Concept]
- lipid-associated sialic acid [MeSH Supplementary Concept]
- lipofectamine [MeSH Supplementary Concept]
- lipomaiz [MeSH Supplementary Concept]
- lipopigments [MeSH Supplementary Concept]
- lodyne S [MeSH Supplementary Concept]
- lyprinol [MeSH Supplementary Concept]
- malhamensilipin A [MeSH Supplementary Concept]
- maxifectin [MeSH Supplementary Concept]
- medullipin I [MeSH Supplementary Concept]
- medullipin II [MeSH Supplementary Concept]
- metafectene [MeSH Supplementary Concept]
- mollenyne A [MeSH Supplementary Concept]
- mutalipocin I [MeSH Supplementary Concept]
- mutalipocin II [MeSH Supplementary Concept]
- mytilipin A [MeSH Supplementary Concept]
- natuderm [MeSH Supplementary Concept]
- novosept [MeSH Supplementary Concept]
- oil A [MeSH Supplementary Concept]
- oligofectamine [MeSH Supplementary Concept]
- oncolipids [MeSH Supplementary Concept]
- ornithine containing aminolipid [MeSH Supplementary Concept]
- osmolite [MeSH Supplementary Concept]
- ossobolin [MeSH Supplementary Concept]
- paecilaminol [MeSH Supplementary Concept]
- pelnicol [MeSH Supplementary Concept]
- peritoneal dialysate depressor II [MeSH Supplementary Concept]
- persil [MeSH Supplementary Concept]
- phillips corona ointment [MeSH Supplementary Concept]
- phthiocerol dimycocerosate [MeSH Supplementary Concept]
- pigment 462 [MeSH Supplementary Concept]
- poly(ethylenimine)-co-(N-(2-aminoethyl) ethyleneimin)-co-N-(N-cholesteryloxycarbonyl-(2-aminoethyl)ethylenimine) [MeSH Supplementary Concept]
- propenediester lipid [MeSH Supplementary Concept]
- prosparol [MeSH Supplementary Concept]
- replens [MeSH Supplementary Concept]
- roseoferin [MeSH Supplementary Concept]
- sapo kalinus [MeSH Supplementary Concept]
- scherilan [MeSH Supplementary Concept]
- serine containing aminolipid [MeSH Supplementary Concept]
- serinolamide A [MeSH Supplementary Concept]
- serinolamide C [MeSH Supplementary Concept]
- serinolamide D [MeSH Supplementary Concept]
- shishididemniol A [MeSH Supplementary Concept]
- shishididemniol B [MeSH Supplementary Concept]
- softisan 100 [MeSH Supplementary Concept]
- sorgoleone [MeSH Supplementary Concept]
- specific substance maruyama [MeSH Supplementary Concept]
- spisulosine [MeSH Supplementary Concept]
- sterodin [MeSH Supplementary Concept]
- suberin [MeSH Supplementary Concept]
- sulfated lactosyl archaeol [MeSH Supplementary Concept]
- sulfolipids [MeSH Supplementary Concept]
- tautomycetin [MeSH Supplementary Concept]
- thymosterin B [MeSH Supplementary Concept]
- tripmycin A [MeSH Supplementary Concept]
- tryphine [MeSH Supplementary Concept]
- unifectin [MeSH Supplementary Concept]
- vinilin [MeSH Supplementary Concept]
Related MeSH term(s)
- lipid metabolism [MeSH Descriptor]
See also
- fats [MeSH Descriptor]
- hyperlipidemias [MeSH Descriptor]
- hypolipidemic agents [MeSH Descriptor]
See also (suggested by CISMeF)
- lipid metabolism disorders [MeSH Descriptor]
- lipid metabolism, inborn errors [MeSH Descriptor]
See also inter- (CISMeF)
- lipidogram [CISMeF Querying Strategy]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lipid [FMA entity]
- Lipid [LOINC component]
- Lipid [NCIt concept]
- Lipid (substance) [SNOMED CT concept]
- Lipids [LOINC component]
- lipid [Radlex concept]
- lipid, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients